SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-059941
Filing Date
2024-05-10
Accepted
2024-05-10 17:07:07
Documents
8
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2411645-1_pre14a.htm PRE 14A 865462
2 GRAPHIC bc_netloss-bw.jpg GRAPHIC 45827
3 GRAPHIC bc_tsr-bw.jpg GRAPHIC 48582
4 GRAPHIC lg_jaguarhealth-4c.jpg GRAPHIC 33425
5 GRAPHIC px_24jaguarproxy1pg01-bw.jpg GRAPHIC 220780
6 GRAPHIC px_24jaguarproxy1pg02-bw.jpg GRAPHIC 313432
7 GRAPHIC px_24jaguarproxy1pg03-bw.jpg GRAPHIC 397790
8 GRAPHIC sg_lisaaconte-bw.jpg GRAPHIC 12231
  Complete submission text file 0001104659-24-059941.txt   2278187
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36714 | Film No.: 24935937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)